ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Virbac SA

Virbac SA (VIRP)

350,00
-1,00
(-0,28%)
Geschlossen 06 Juni 5:30PM

Virbac SA (VIRP) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
350,00
( -0,28% )
Gebot
346,00
Fragen
360,00
Volumen
4.333
347,50 Tagesbereich 359,00
296,00 52-Wochen-Bereich 389,50
Marktkapitalisierung
Handelsende
351,00
Handelsbeginn
350,50
Letzte Trade
2
@
350
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
4.772 €
Ausgegebene Aktien
8.377.824
Dividendenrendite (LTM)
1,45 (0,40%)
Kurs-Gewinn-Verhältnis
19,92
Gewinn pro Aktie (EPS)
18
Erlöse (LTM)
1,46B
Nettogewinn (LTM)
150,89M

Über Virbac SA

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline... Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx soft chews formulated with ursolic acid that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, immunology, nutrition, petfood, and pharmaceutical products. In addition, the company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Hauptsitz
Carros, France
Gegründet
1968
Virbac SA is listed in the Healthcare sector of the Euronext with ticker VIRP. The last closing price for Virbac was 351,00 €. Over the last year, Virbac shares have traded in a share price range of 296,00 € to 389,50 €.

Virbac currently has 8.377.824 shares in issue. The market capitalisation of Virbac is 2,93 € billion. Virbac has a price to earnings ratio (PE ratio) of 19.92.

VIRP Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-10.5-2.91262135922360.5367.53383171352.067716DE
4-20-5.405405405413703723384017354.46778187DE
12164.79041916168334389.5326.54895356.71834501DE
26-5-1.40845070423355389.5326.54636356.65741884DE
52216.3829787234329389.52964331346.77866099DE
15652.517.6470588235297.5400232.54319324.19577892DE
26067.523.8938053097282.5448.52154983324.98352888DE

VIRP - Frequently Asked Questions (FAQ)

What is the current Virbac SA share price?
The current share price of Virbac SA is 350,00 €
How many Virbac SA shares are in issue?
Virbac SA has 8.377.824 shares in issue
What is the market cap of Virbac SA?
The market capitalisation of Virbac SA is EUR 2,93B
What is the 1 year trading range for Virbac SA share price?
Virbac SA has traded in the range of 296,00 € to 389,50 € during the past year
What is the PE ratio of Virbac SA?
The price to earnings ratio of Virbac SA is 19,92
What is the cash to sales ratio of Virbac SA?
The cash to sales ratio of Virbac SA is 2,05
What is the registered address of Virbac SA?
The registered address for Virbac SA is 13e rue LID - BP 27, Carros, Provence-Alpes-Côte d'Azur, 06511
What is the Virbac SA website address?
The website address for Virbac SA is corporate.virbac.com
Which industry sector does Virbac SA operate in?
Virbac SA operates in the Pharmaceuticals sector

VIRP Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen